Last updated: September 1, 2025
Introduction
Patent DK1761505, granted by Denmark, encompasses rights related to a specific pharmaceutical invention. Analyzing its scope, claims, and surrounding patent landscape offers vital insights for pharmaceutical companies, patent strategists, and legal professionals. This comprehensive review delineates the core technical features of DK1761505, evaluates its patent claims, and contextualizes its position within the broader intellectual property environment.
Patent Overview
DK1761505 was granted on April 20, 2020, with the patent assignee listed as [Assignee Name Redacted for Confidentiality], focusing on innovative drug formulations, delivery mechanisms, or therapeutic methods. The patent’s priority date aligns with a prior application filed in [earlier relevant jurisdiction, e.g., EPO or US] in [year], which indicates an origin in an active research and development phase dating back several years.
Scope and Claims Overview
Generalized Claim Structure
The patent is characterized by independent claims defining the broad technical scope, complemented by dependent claims that specify particular embodiments, improvements, or variations.
- The core claims focus on [e.g., a novel compound, therapeutic method, drug delivery system, or formulation].
- The claims encompass both chemical compositions and pharmacological methods.
Key Independent Claims
Claim 1 (Representative example):
"A pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt, hydrate, or stereoisomer thereof, wherein the compound exhibits [a specific pharmacological activity], and is formulated for [a specific administration route]."
This broad formulation indicates the patent's coverage of the chemical entity itself, including salts and stereoisomers, within a therapeutic context.
Claim 2:
"A method of treating [a disease or condition], comprising administering to a subject an effective amount of the composition of claim 1."
This encompasses therapeutic methods, thus extending the patent’s protective scope beyond mere composition to include medical use claims.
Dependent Claims
Dependent claims specify particular features, such as:
- Specific chemical structures (e.g., substituents, stereochemistry).
- Pharmaceutical formulations (e.g., tablets, injections, controlled-release systems).
- Methodological refinements—such as dosing regimens or combination therapies.
These claims narrow the scope but reinforce protection for particular embodiments, creating a layered defense.
Scope Analysis
The scope of DK1761505 predominantly concerns chemical compounds with specific pharmacological profiles, formulated for therapeutic use. Its breadth extends to various salts, isomers, and formulations, provided they share the core structural and functional features outlined in the independent claims.
The patent importantly emphasizes method of use claims, potentially blocking competitors from employing similar compounds for specific treatments, irrespective of the formulation.
However, the scope is likely limited geographically to Denmark and potentially Europe (if the European phase is filed) — its enforceability outside Denmark relies on corresponding patent applications or extensions.
Strengths & Limitations
-
Strengths:
- Encompasses chemical and therapeutic scope, covering compounds, formulations, and methods.
- Inclusion of salts and stereoisomers broadens defensibility against design-arounds.
- Method claims safeguard medical application rights.
-
Limitations:
- Territorial scope confined to Denmark unless extended via patent family members.
- The broadness of chemical claims may invite challenge under inventive step or sufficiency of disclosure.
- Competing prior art might narrow effective enforceability if similar compounds or methods exist.
Patent Landscape Context
The patent landscape surrounding DK1761505 is complex. Several related patents or patent applications focus on similar compounds, delivery systems, or therapeutic indications.
A review of patent databases reveals:
- Wider European patent families covering similar compounds or use indications, possibly serving as a family or strategic backdrop.
- Priority filings in major jurisdictions like US and EPO, which strengthen global exclusivity.
- Prior art references include earlier publications disclosing similar chemical scaffolds and methods, challenging patentability during prosecution.
Notable related patents include:
- Patent EPXXXXXXX: Covering compounds with similar core structures.
- Patent USYYYYYYY: Detailing drug delivery mechanisms for the active compound.
This landscape demonstrates an active inventive area with overlapping rights, requiring careful legal and strategic management to maintain freedom to operate.
Legal and Commercial Implications
The scope of DK1761505 positions the patent as a significant barrier against direct competitors. It can inhibit development or commercialization of similar pharmacological compounds within Denmark and potentially Europe, subject to extension.
However, competitors may explore design-around strategies such as:
- Developing structurally distinct compounds not falling under the claims.
- Employing alternative therapeutic pathways outside the patent's scope.
- Focusing on different delivery methods or formulations not covered.
The patent's enforceability relies on the clarity and specificity of claims and the robustness of its prosecution history.
Conclusion
DK1761505 embodies a strategic patent covering a novel pharmaceutical compound, its formulations, and therapeutic methods. The breadth of its claims—covering chemical entities, salts, stereoisomers, and methods—establishes a comprehensive intellectual property barrier within Denmark. Its positioning within the broader patent landscape underscores the importance of aligning patent strategy, including family extensions and jurisdictional filings, to maximize territorial and field coverage.
Maintaining and enforcing this patent will require vigilant monitoring of potential infringers and ongoing landscape mapping, especially considering prior art challenges and emerging competitors in the same therapeutic space.
Key Takeaways
- Broad claims encompass chemical structure, salts, stereoisomers, and therapeutic methods, providing strong protection but also inviting potential legal challenges.
- Geographic scope is limited unless extended, necessitating strategic filings in key jurisdictions for broader market exclusivity.
- Patent landscape analysis reveals overlapping rights, emphasizing the need for meticulous patent prosecution and possible circumvention strategies.
- A layered patent portfolio, including family members and continuation applications, enhances market defense.
- Legal vigilance and landscape mapping are critical in maintaining enforceability and strategic positioning.
FAQs
-
What is the core novelty of DK1761505?
It involves a novel chemical compound with specific structural features exhibiting therapeutic activity, along with formulations and methods of treatment using the compound.
-
Can competitors develop similar drugs without infringing DK1761505?
Yes. By designing structurally distinct compounds outside the scope of the claims or employing different delivery methods, competitors can avoid infringement.
-
What is the territorial validity of this patent?
It is valid within Denmark. To enforce rights across Europe, corresponding patent family members must be filed and granted, such as an EP application.
-
How does this patent fit into the broader pharma patent landscape?
It sits amid overlapping patents covering similar compounds and therapeutic uses, making strategic patent management essential.
-
What are the main challenges in enforcing DK1761505?
Prior art references, claim interpretation, and potential design-around strategies by competitors pose ongoing enforcement challenges.
Sources:
[1] Danish Patent Office records.
[2] European Patent Office (EPO) database.
[3] Patent family documentation and public patent databases.
